MedPath

Letrozole Step up Protocol for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome

Not Applicable
Completed
Conditions
Polycystic Ovarian Syndrome (PCOS)
Infertility
Interventions
Drug: Letrozol step up dose
Drug: Conventional fixed dose letrozole
Registration Number
NCT07143682
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Brief Summary

The goal of this clinical trial is to learn if drug letrozole in step up dose works better to treat anovulation in infertile women with polycystic ovary syndrome. It will also learn about the safety of drug letrozole in step up dose. The main questions it aims to answer are:

* Does drug letrozole in step up dose results in better ovarian response?

* What medical problems do participants have when taking drug letrozole in step up dose? Researchers will compare drug letrozole step up dose to a standard low dose to see if the step up dose works to achieve better ovarian response.

Participants will:

* Take drug letrozole step up or standard low dose from day 2 of menstruation for 3 cycles

* Visit the clinic on day 12-16 of menstral cycle for checkups and tests

* Keep a diary of any untoward symptoms

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
70
Inclusion Criteria
  • PCOS women with subfertility
  • Selected for ovulation induction
Exclusion Criteria
  • Body mass index (BMI) ˂18 and ≥30 kg/m2,
  • Women with other infertility factors (endometriosis, suspected tubal factor, and uterine causes of infertility)
  • Male factor infertility

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Letrozole step upLetrozol step up doseTab letrozole 2.5mg one, two, three, and four tablets once daily from 2nd/3rd day of the menstrual cycle for 4 days
Conventional fixed dose letrozoleConventional fixed dose letrozoleTab letrozole 5mg once daily for 5 days started from the 2nd/3rd day of the menstrual cycle
Primary Outcome Measures
NameTimeMethod
Preovulatory follicle (mean diameter ≥18mm)3 months
Endometrial thickness ( 7mm or more)3 months
Secondary Outcome Measures
NameTimeMethod
Pregnancy4 months

Trial Locations

Locations (1)

Bangabandhu Sheikh Mujib Medical University

🇧🇩

Dhaka, Dhaka Division, Bangladesh

Bangabandhu Sheikh Mujib Medical University
🇧🇩Dhaka, Dhaka Division, Bangladesh

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.